These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26714557)

  • 1. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
    Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
    Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
    Baandrup L; Faber MT; Aalborg GL; Kjaer SK
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian cancer and borderline tumors].
    Bjørge T; Engeland A; Hansen S; Tropé CG
    Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2471-5. PubMed ID: 9667122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
    Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
    Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007 in Niigata.
    Yahata T; Banzai C; Tanaka K;
    J Obstet Gynaecol Res; 2012 Apr; 38(4):645-50. PubMed ID: 22381138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
    Guleria S; Jensen A; Kjær SK
    Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
    Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C
    BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian and tubal cancer in Denmark: an update on incidence and survival.
    Gottschau M; Mellemkjaer L; Hannibal CG; Kjaer SK
    Acta Obstet Gynecol Scand; 2016 Oct; 95(10):1181-9. PubMed ID: 27454324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline and invasive epithelial ovarian tumors in young women.
    Carter J; Fowler J; Carlson J; Carson L; Twiggs LB
    Obstet Gynecol; 1993 Nov; 82(5):752-6. PubMed ID: 8414321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.